异常蛋白质聚合在肌缩侧面硬化症中的异常蛋白质聚合
Huaixiu Wang1,2, Rong Zeng3
1Department Neurology, Shanxi Provincial Peoples Hospital: Fifth Hospital of Shanxi Medical University, Taiyuan, 030012, China. 976378008@qq.com.
Journal of neurology
|June 13, 2024
概括
肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,其特点是异常蛋白质聚合 (APA). 了解 APA 的理解
科学领域:
- 神经科学是一个神经科学.
- 病理学 病理学 病理学
- 生物化学 生化学
背景情况:
- 肌缩侧面硬化症 (ALS) 是一种致命的神经退行性疾病,其机制尚不清楚.
- 目前针对ALS的治疗方法由于其异质性和复杂的病理学而受到限制.
- 异常蛋白聚合 (APA) 是不同类型的ALS病例的共同标志.
研究的目的:
- 为了阐明异常蛋白聚合 (APA) 异常蛋白聚合 (APA) 在肌缩侧面硬化症 (ALS) 的病理机制.
- 探索潜在的治疗策略,针对ALS中的APA.
- 通过对蛋白质聚合的研究,增强对ALS病原学的理解.
主要方法:
- 关于ALS病理机制的现有文献的审查和综合.
- 分析异常蛋白聚合 (APA) 在疾病进展中的作用.
- 识别和讨论与APA相关的候选治疗目标.
主要成果:
- 异常蛋白聚合 (APA) 是肌缩侧面硬化症 (ALS) 发病的一个核心和复杂的特征.
- 研究APA的上游和下游影响为ALS提供了关键的见解.
- 目前正在探索针对APA的几种候选治疗策略.
结论:
- 了解异常蛋白聚合 (APA) 的复杂病理机制对于开发有效的肌缩侧面硬化症 (ALS) 治疗方法至关重要.
- 准APA为未来的ALS治疗提供了一个有希望的途径.
- 对ALS中APA的进一步研究是有必要的,以对抗这种毁灭性的疾病.
更多相关视频
07:14Optogenetic Phase Transition of TDP-43 in Spinal Motor Neurons of Zebrafish Larvae
Published on: February 25, 2022
6.0K
13:31Novel Atomic Force Microscopy Based Biopanning for Isolation of Morphology Specific Reagents against TDP-43 Variants in Amyotrophic Lateral Sclerosis
Published on: February 12, 2015
8.8K
相关概念视频
Amyloid Fibrils
9.5K
Amyloid fibrils are aggregates of misfolded proteins. Under most circumstances, misfolded proteins are either refolded by chaperone proteins or degraded by the proteasome. However, in the case of a mutation or a disease, these proteins can accumulate to form large clusters and often further assemble to form elongated fibers, called fibrils.
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
Amyloid deposits were observed as early as 1639 in the liver and the spleen. In 1854, Rudolph Virchow performed iodine staining,...
9.5K
Cross-bridge Cycle
117.3K
As muscle contracts, the overlap between the thin and thick filaments increases, decreasing the length of the sarcomere—the contractile unit of the muscle—using energy in the form of ATP. At the molecular level, this is a cyclic, multistep process that involves binding and hydrolysis of ATP, and movement of actin by myosin.
117.3K
